RecruitingNot Applicable

GDF-15 and Early Outcomes After LVAD Implantation

Turkey (Türkiye)48 participantsStarted 2026-02-04

Plain-language summary

This observational study aims to investigate the association between preoperative GDF-15 levels and early postoperative outcomes in patients undergoing left ventricular assist device (LVAD) implantation. The study will evaluate whether elevated preoperative GDF-15 levels are associated with adverse early outcomes, including postoperative complications and mortality. The findings may help improve preoperative risk assessment and identify high-risk patients before LVAD implantation.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria:Adults aged 18 years and older Patients with advanced heart failure undergoing LVAD implantation Availability of preoperative GDF-15 measurement Ability to provide written informed consent or consent provided by a legally authorized representative, according to local regulations - Exclusion Criteria:Age under 18 years Active infection Active malignancy Severe hepatic failure Missing study data Refusal to participate \-

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Early Postoperative Mortality

Timeframe: 30 days after LVAD implantation

Trial details

NCT IDNCT07497308

SponsorAkdeniz University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-08-10

Contact for this trial

emel gündüz, md

+902422496000 dregunduz@hotmail.com

View on ClinicalTrials.gov More Advanced Heart Failure trials